Cargando…

Automated Metrics for Potential Adverse Outcomes in Pediatric Antimicrobial Stewardship

BACKGROUND: Many prescribers may question the safety of restricting antibiotic use at their own institution. Measurement of potential adverse outcomes relevant to antimicrobial stewardship may increase the acceptability of stewardship interventions. METHODS: Antibiotic prescribing, admit/discharge/t...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sameer, Reuter, Caroline, Patel, Rupal, Kociolek, Larry, Jones, Roderick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631553/
http://dx.doi.org/10.1093/ofid/ofx163.1293
Descripción
Sumario:BACKGROUND: Many prescribers may question the safety of restricting antibiotic use at their own institution. Measurement of potential adverse outcomes relevant to antimicrobial stewardship may increase the acceptability of stewardship interventions. METHODS: Antibiotic prescribing, admit/discharge/transfer (ADT) data, vital sign (VS) trends, white blood cell counts (WBC), microbiology antibiotic susceptibility results (ASR), and medication administration record (MAR) data were reviewed for 2620 patients hospitalized at Lurie Children’s Hospital from April 2013 to March 2017. Metrics were created using discrete data elements derived from the electronic health record (EHR). The sensitivity (to detect an adverse outcome) and specificity (to avoid false detection of an adverse outcome) were measured in comparison to manual review of the medical record. Data were presented to 50 pediatricians and pediatric subspecialists who were asked to rate (Likert scale 1–5) the perceived importance of the metrics for patient safety and usefulness of the metrics for their prescribing. RESULTS: The metrics, data elements, sensitivity, specificity, and ratings by prescribers for importance and usefulness are listed below. CONCLUSION: Metrics derived from the EHR can offer automated surveillance of infection-related adverse outcomes relevant to antimicrobial stewardship. At the institutional level, these metrics are a potential tool to ensure the safety and acceptability of stewardship interventions. DISCLOSURES: S. Patel, Merck Pharmaceuticals: Investigator, Research grant; R. Patel, Merck Pharmaceuticals: Investigator, Research grant; L. Kociolek, Merck Pharmaceuticals: Investigator, Research grant.